Morning Market Gainers

shares jumped 122.15% to $53.16 after

announced its plans to acquire up to 56.3% stake in Foundation Medicine for $1.03 billion. Roche will commence tender offer at $50.00 per share.

shares surged 45.10% to $22.78 on merger deal with OnCore Biopharma Inc.

climbed 42.32% to $3.43 after the company announced the publication of Phase 2 data evaluating CPX-351 in adult patients with first-relapse acute myeloid leukemia.

rose 23.88% to $4.7199 after the company reported Q2 earnings of $0.07 per share on revenue of $14.50 million.

shares gained 18.92% to $15.59 after the company announced the commencement of a 9.2 million secondary public offering of its shares of Abengoa Yield by selling shareholder Abengoa.

shares jumped 8.45% to $45.45 after

agreed to buy NPS Pharmaceuticals for $5.2 billion, or $46 per share.

rose 8.08% to $189.84 after

reported the purchase of MWI Veterinary Supply for $190 per share in cash. Bristol-Myers Squibb Company

climbed 4.58% to $63.08. Bristol-Myers Squibb announced that Phase 3 study of Opdivo vs Docetaxel in patients with second-line squamous cell NSCLC met its endpoint.

shares gained 5.70% to $61.97 after the company raised its Q4 forecast.

rose 3.96% to $27.82 after the company raised its Q1 sales forecast.

surged 3.94% to $0.53 after the FDA announced the approval of Cytori U.S. pivotal scleroderma trial.

shares climbed 2.29% to $22.64. Aegerion Pharmaceuticals projected Q4 sales of $49.30 million to $51.30 million. It also expected FY15 global net product sales growth in 30% to 50% range.